Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > what a difference in volume today

<< Previous

Bullboard Posts

Next >>

Comment by Dumbeldorfwhiteon Nov 01, 2023 4:57pm

284 Views

Post# 35712137

RE:RE:RE:RE:RE:what a difference in volume today

Yeah 10 years ago that was the case, but with delays and all these other companies beating TLT to the finish line it's not surprising to see, besides as a competitor such as Merck you see how much difficulty there is raising money why would u try and JV when they could possibly go broke

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record